ADVERTISEMENT

Johnson & Johnson

Explained | How advocates pushed big pharma to cut tuberculosis drug prices

J&J’s global patent of bedaquiline ended on July 18, but the company continued to control access to the drug in many low-income countries where the vast majority of TB cases occur.

14 August 2023, 12:02 IST

Explained | How advocates pushed big pharma to cut tuberculosis drug prices

Explained | How advocates pushed big pharma to cut tuberculosis drug prices

Explained | How advocates pushed big pharma to cut tuberculosis drug prices

14 August 2023, 12:02 IST

US FDA approves Johnson & Johnson's blood cancer therapy

The therapy, talquetamab-tgvs branded as Talvey, belongs to a class called bispecific antibodies designed to bring a cancer cell and an immune cell together so the body's immune system can kill the cancer.

10 August 2023, 11:52 IST

US FDA approves Johnson & Johnson's blood cancer therapy

US FDA approves Johnson & Johnson's blood cancer therapy

US FDA approves Johnson & Johnson's blood cancer therapy

10 August 2023, 11:52 IST

J&J must pay $18.8 mn in California talc-cancer trial

Jurors in state court in state court in Oakland concluded J&J’s baby powder helped cause Anthony Hernandez Valadez’s mesothelioma, a specific type of cancer.

19 July 2023, 10:41 IST

Johnson & Johnson must pay $18.8 million in California talc-cancer trial

Johnson & Johnson must pay $18.8 million in California talc-cancer trial

J&J must pay $18.8 mn in California talc-cancer trial

19 July 2023, 10:41 IST

Eli Lilly becomes world’s biggest health-care firm

Lilly’s climb has been fueled by its drugs to treat obesity led by Mounjaro, already approved to treat diabetes, along with an experimental treatment for Alzheimer’s.

06 July 2023, 04:11 IST

Eli Lilly surpasses UnitedHealth as world’s biggest health-care firm

Eli Lilly surpasses UnitedHealth as world’s biggest health-care firm

Eli Lilly becomes world’s biggest health-care firm

06 July 2023, 04:11 IST

J&J consumer unit named in talcum powder cancer claims

The news comes as Johnson & Johnson (J&J) said it's seeking up to a $42.95 billion valuation for Kenvue in its initial public offering

27 April 2023, 06:34 IST

J&J's consumer unit named in talcum powder cancer claims: Report

J&J's consumer unit named in talcum powder cancer claims: Report

J&J consumer unit named in talcum powder cancer claims

27 April 2023, 06:34 IST

Johnson & Johnson reaches $8.9 billion talc settlement

The proposed settlement would be paid out over 25 years through a subsidiary, Johnson and Johnson said in a securities filing

05 April 2023, 00:31 IST

Johnson & Johnson to settle talc cancer claims for $8.9 bn

Johnson & Johnson to settle talc cancer claims for $8.9 bn

Johnson & Johnson reaches $8.9 billion talc settlement

05 April 2023, 00:31 IST

Can't use hammer for ant: HC allows sale of J&J powder

HC quashes Maharashtra govt order revoking the company's license

11 January 2023, 09:03 IST

'Cannot use a hammer to kill an ant': HC permits J&J to manufacture and sell its baby powder

'Cannot use a hammer to kill an ant': HC permits J&J to manufacture and sell its baby powder

Can't use hammer for ant: HC allows sale of J&J powder

11 January 2023, 09:03 IST

Bombay HC orders fresh testing of J&J baby powder

The HC posted the matter for further hearing on November 30

16 November 2022, 10:29 IST

Bombay HC orders fresh testing of Johnson & Johnson baby powder; company can manufacture but not sell it

Bombay HC orders fresh testing of Johnson & Johnson baby powder; company can manufacture but not sell it

Bombay HC orders fresh testing of J&J baby powder

16 November 2022, 10:29 IST

J&J sells Telangana plant as demand slumps: Report

This is the second plant sold by J&J in the country

18 October 2022, 05:37 IST

Johnson & Johnson sells Telangana plant as demand slumps: Report

Johnson & Johnson sells Telangana plant as demand slumps: Report

J&J sells Telangana plant as demand slumps: Report

18 October 2022, 05:37 IST

J&J to end sale of talc-based baby powder globally

The company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer

12 August 2022, 11:33 IST

Johnson & Johnson to end sale of talc-based baby powder globally from 2023

Johnson & Johnson to end sale of talc-based baby powder globally from 2023

J&J to end sale of talc-based baby powder globally

12 August 2022, 11:33 IST